FDA Inspection
Beigene (Suzhou) Co., Ltd.Beigene (Suzhou) Co., Ltd. – FDA Inspection, Jun 16, 2023
Record Details
This FDA Inspection record concerns Beigene (Suzhou) Co., Ltd., with an inspection on June 16, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5c7e81b4-6666-4251-a25b-f579017fe7a5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1217639
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Beigene (Suzhou) Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 28, 2019 | Not classified | Office of Inspections and Investigations |
Other documents for Beigene (Suzhou) Co., Ltd.
- FDA Inspection 1103267 - 2019-08-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.